Price Alert

Ascentage Pharma Group In... (AAPG)

NASDAQ: AAPG · Real-Time Price · USD

40.41

0.52 (1.30%)

At close: Sep 12, 2025, 1:00 PM

Ascentage Pharma International Statistics

Share Statistics

Ascentage Pharma International has 92.8M shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	92.8M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	n/a
Shares Floating	n/a
Failed to Deliver (FTD) Shares	123
FTD / Avg. Volume	1.17%

Short Selling Information

The latest short interest is 16.89K, so 0.02% of the outstanding shares have been sold short.

Short Interest	16.89K
Short % of Shares Out	0.02%
Short % of Float	0.02%
Short Ratio (days to cover)	2.16

Valuation Ratios

The PE ratio is -94.51 and the forward PE ratio is 45.11. Ascentage Pharma International's PEG ratio is 1.

PE Ratio	-94.51
Forward PE	45.11
PS Ratio	39.07
Forward PS	11
PB Ratio	145.04
P/FCF Ratio	-282.48
PEG Ratio	1

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Ascentage Pharma International.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 6.32.

Current Ratio	1.26
Quick Ratio	1.26
Debt / Equity	6.32
Debt / EBITDA	-7.02
Debt / FCF	-12.3
Interest Coverage	-5.74

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$1.73M
Profits Per Employee	$-715.05K
Employee Count	567
Asset Turnover	0.37
Inventory Turnover	4.41

Taxes

Income Tax	10.43M
Effective Tax Rate	-2.64%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 0.92, so Ascentage Pharma International's price volatility has been higher than the market average.

Beta	0.92
52-Week Price Change	n/a
50-Day Moving Average	41.01
200-Day Moving Average	n/a
Relative Strength Index (RSI)	45.67
Average Volume (20 Days)	10,495

Income Statement

In the last 12 months, Ascentage Pharma International had revenue of 980.65M and earned -405.43M in profits. Earnings per share was -0.75.

Revenue	980.65M
Gross Profit	951.57M
Operating Income	-369.73M
Net Income	-405.43M
EBITDA	-237.63M
EBIT	-330.8M
Earnings Per Share (EPS)	-0.75

Full Income Statement

Balance Sheet

The company has 1.24B in cash and 1.67B in debt, giving a net cash position of -431.92M.

Cash & Cash Equivalents	1.24B
Total Debt	1.67B
Net Cash	-431.92M
Retained Earnings	-5.77B
Total Assets	2.62B
Working Capital	307.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -111.36M and capital expenditures -24.29M, giving a free cash flow of -135.65M.

Operating Cash Flow	-111.36M
Capital Expenditures	-24.29M
Free Cash Flow	-135.65M
FCF Per Share	-0.45

Full Cash Flow Statement

Margins

Gross margin is 97.03%, with operating and profit margins of -37.7% and -41.34%.

Gross Margin	97.03%
Operating Margin	-37.7%
Pretax Margin	-40.31%
Profit Margin	-41.34%
EBITDA Margin	-24.23%
EBIT Margin	-37.7%
FCF Margin	-13.83%

Dividends & Yields

AAPG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for AAPG.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-2.13
Piotroski F-Score	3